This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Myriad Genetics Inc (MYGN)

NASDAQ: Services

Company Balance Sheet
Jun 2014 Jun 2013 Jun 2012 Jun 2011
Assets
Cash and Equivalents 64.82M 104.07M 86.35M 52.68M
Receivables 85.07M 97.71M 63.10M 50.85M
Inventories 23.92M 5.01M 11.57M 5.67M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 322.42M 483.99M 422.49M 418.26M
Property, Plant & Equipment, Gross 99.61M 84.20M 72.53M 64.11M
Accumulated Depreciation & Depletion 65.01M 56.60M 48.30M 41.03M
Property, Plant & Equipment, Net 34.59M 27.60M 24.23M 23.08M
Intangibles 205.31M 13.33M 15.72M 16.72M
Other Non-Current Assets 89.12M 193.42M 140.69M 70.86M
Total Non-Current Assets 501.39M 319.83M 268.14M 192.57M
Liabilities & Shareholder Equity
Total Assets 823.81M 803.82M 690.64M 610.83M
Accounts Payable 23.08M 18.13M 10.14M 11.40M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 80.58M 64.51M 44.97M 34.39M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 10.01M 9.65M
Other Non-Current Liabilities 24.24M 10.72M 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 24.24M 10.72M 10.01M 9.65M
Total Liabilities 104.82M 75.23M 54.98M 44.04M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 719.00M 728.59M 635.66M 566.79M
Common Par 735.00K 806.00K 826.00K 862.00K
Additional Paid In Capital 717.77M 697.35M 647.68M 604.41M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 2.00M 30.87M -12.68M -38.63M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -1.52M -424.00K -162.00K 151.00K
Total Capitalization 719.00M 728.59M 635.66M 566.79M
Total Equity 719.00M 728.59M 635.66M 566.79M
Total Liabilities & Stock Equity 823.81M 803.82M 690.64M 610.83M
Total Common Shares Outstanding 73.50M 80.58M 82.57M 86.24M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 75.73M 80.95M 84.61M 89.79M
Diluted Weighted Shares Outstanding 78.18M 83.33M 86.46M 91.70M
Number of Employees 1649 1325 1169 1057
Number of Part-Time Employees 0 0 0 0
MYGN News

MYGN Myriad Genetics Inc

Analysts Ratings for MYGN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 6 6 7 8
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 2
GET MYGN ANALYST REPORT

Brokerage Partners

MYGN Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs